نتائج البحث - "Peter Kabos"

11

دورية أكاديمية

Supplementary Table S3 from Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

مصطلحات موضوعية: Cancer, Clinical Research and Trials, Breast Cancer, Clinical Trial Results, Phase I clinical trials

العلاقة: https://figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Phase_Ia_b_Study_of_Giredestrant_Palbociclib_and_Luteinizing_Hormone-Releasing_Hormone_Agonists_in_Estrogen_Receptor_Positive_HER2-Negative_Locally_Advanced_Metastatic_Breast_Cancer/25232177Test

الإتاحة: https://doi.org/10.1158/1078-0432.25232177.v1Test

View record in BASE

12

دورية أكاديمية

Supplementary Figure S2 from Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

مصطلحات موضوعية: Cancer, Clinical Research and Trials, Breast Cancer, Clinical Trial Results, Phase I clinical trials

العلاقة: https://figshare.com/articles/journal_contribution/Supplementary_Figure_S2_from_Phase_Ia_b_Study_of_Giredestrant_Palbociclib_and_Luteinizing_Hormone-Releasing_Hormone_Agonists_in_Estrogen_Receptor_Positive_HER2-Negative_Locally_Advanced_Metastatic_Breast_Cancer/25232189Test

الإتاحة: https://doi.org/10.1158/1078-0432.25232189.v1Test

View record in BASE

13

دورية أكاديمية

Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study ... : اعتبارات ضمان الجودة في العلاج الصيدلاني الإشعاعي قياس الجرعات باستخدام الخطة الجرعة: دراسة الوكالة الدولية للطاقة الذرية ...

المؤلفون: Gunjan Kayal, Nathaly Barbosa Parada, Carlos Calderón Marín, Ludovic Ferrer, José-Alejandro Fragoso-Negrín, Darko Grošev, Santosh Kumar Gupta, Nur Rahmah Hidayati, T.C.G. Moalosi, G. Poli, Parul Thakral, Virginia Tsapaki, Sébastien Vauclin, Alberto Gil, Peter Kabos, R. Hobbs, Manuel Bardiès

العلاقة: https://dx.doi.org/10.60692/7c936-vf441Test

الإتاحة: https://doi.org/10.60692/agrac-wn08210.60692/7c936-vf441Test

View record in BASE

14

دورية أكاديمية

Supplementary Table S1 from Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer

المؤلفون: Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman, Pavani Chalasani, Andrew J. Brenner, Alison Stopeck, Hannah Parris, Dexiang Gao, Tessa McSpadden, Jose Mayordomo, Jennifer R. Diamond, Peter Kabos, Virginia F. Borges

مصطلحات موضوعية: Cancer

العلاقة: https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Safety_and_Efficacy_of_Tucatinib_Letrozole_and_Palbociclib_in_Patients_with_Previously_Treated_HR_HER2_Breast_Cancer/24825276Test

الإتاحة: https://doi.org/10.1158/1078-0432.24825276.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Safety_and_Efficacy_of_Tucatinib_Letrozole_and_Palbociclib_in_Patients_with_Previously_Treated_HR_HER2_Breast_Cancer/24825276Test

View record in BASE

15

دورية أكاديمية

Supplementary Fig. S3 from Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer

المؤلفون: Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman, Pavani Chalasani, Andrew J. Brenner, Alison Stopeck, Hannah Parris, Dexiang Gao, Tessa McSpadden, Jose Mayordomo, Jennifer R. Diamond, Peter Kabos, Virginia F. Borges

مصطلحات موضوعية: Cancer

العلاقة: https://figshare.com/articles/journal_contribution/Supplementary_Fig_S3_from_Safety_and_Efficacy_of_Tucatinib_Letrozole_and_Palbociclib_in_Patients_with_Previously_Treated_HR_HER2_Breast_Cancer/24825282Test

الإتاحة: https://doi.org/10.1158/1078-0432.24825282.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S3_from_Safety_and_Efficacy_of_Tucatinib_Letrozole_and_Palbociclib_in_Patients_with_Previously_Treated_HR_HER2_Breast_Cancer/24825282Test

View record in BASE

16

Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience

المؤلفون: Sarah S. Travers, Christine M. Fisher, Peter Kabos, Diana M. Cittelly, D. Ryan Ormond

المصدر: Journal of Neuro-Oncology. 163:115-121

مصطلحات موضوعية: Cancer Research, Neurology, Oncology, Neurology (clinical)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::aa614932334c0e84ab4997aedcc46afeTest
https://doi.org/10.1007/s11060-023-04314-6Test

17

Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER–Medicare study

المؤلفون: Savannah Roy, Stephanie Lakritz, Anna R. Schreiber, Elizabeth Molina, Peter Kabos, Marie Wood, Anthony Elias, Lavanya Kondapalli, Cathy J. Bradley, Jennifer R. Diamond

المصدر: European Journal of Cancer. 185:69-82

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7c196752029a47b25e2002b079d98c39Test
https://doi.org/10.1016/j.ejca.2023.02.014Test

18

Abstract OT3-09-01: Clinical Trial of Alpelisib and Tucatinib in Patients with PIK3CA-Mutant HER2-Positive Metastatic Breast Cancer

المؤلفون: Elena Shagisultanova, Kari B. Wisinski, Chelsea D. Gawryletz, Farrah M. Datko, Diana Medgyesy, Jennifer R. Diamond, Virginia F. Borges, Peter Kabos

المصدر: Cancer Research. 83:OT3-09

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::805b91032953767b61432226556e55eeTest
https://doi.org/10.1158/1538-7445.sabcs22-ot3-09-01Test

19

Abstract P1-10-09: AQP4 inhibition prevents cytotoxic edema of AQP4+ astrocytes but promotes tumor growth of AQP4+ breast cancer brain metastasis

المؤلفون: Maria J. Contreras-Zarate, Karen ALvarez-Eraso, Nicole Tsuji, Peter Kabos, D.Ryan Ormond, Sana Karam, Diana Cittelly

المصدر: Cancer Research. 83:P1-10

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c1fb381e1d90dd371ac1f1ec6093050bTest
https://doi.org/10.1158/1538-7445.sabcs22-p1-10-09Test

20

دورية أكاديمية

Metadata record for the article: Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer

المؤلفون: Lillian M Smyth (10284013), Gerald Batist (387752), Funda Meric-Bernstam (478258), Peter Kabos (3570254), Iben Spanggaard (3948713), Ana Lluch (103419), Komal Jhaveri (10284015), Andrea Varga (514916), Andrea Wong (848459), Alison M. Schram (3772174), Helen Ambrose (10284018), T. Hedley Carr (423605), Elza C de Bruin (9134279), Carolina Salinas-Souza (10284021), Andrew Foxley (10284024), Joana Hauser (10284027), Justin PO Lindemann (10284030), Rhiannon Maudsley (10284033), Robert McEwen (108964), Michele Moschetta (10284035), Myria Nikolaou (10284038), Gaia Schiavon (125070), Pedram Razavi (8906453), Udai Banerji (121001), José Baselga (4431208), David M. Hyman (737881), Sarat Chandarlapaty (90196)

مصطلحات موضوعية: Cancer Genetics, Oncology and Carcinogenesis not elsewhere classified, Clinical Pharmacology and Therapeutics, phase I trial, capivasertib, fulvestrant, metastatic breast cancer, PTEN-mutant, Estrogen-Receptor-Positive Breast Cancer

العلاقة: https://figshare.com/articles/online_resource/Metadata_record_for_the_article_Capivasertib_a_selective_AKT_kinase_inhibitor_in_combination_with_fulvestrant_in_PTEN-mutant_ER-positive_metastatic_breast_cancer_a_non-randomized_controlled_trial/14192345Test

الإتاحة: https://doi.org/10.6084/m9.figshare.14192345Test

View record in BASE

تنقيح النتائج